Skip to main content
Top
Published in: Journal of Cardiovascular Magnetic Resonance 1/2009

Open Access 01-12-2009 | Research

Cardiovascular magnetic resonance parameters of atherosclerotic plaque burden improve discrimination of prior major adverse cardiovascular events

Authors: Venkatesh Mani, Paul Muntner, Samuel S Gidding, Silvia H Aguiar, Hamza El Aidi, Karen B Weinshelbaum, Hiroaki Taniguchi, Rob van der Geest, Johan HC Reiber, Sameer Bansilal, Michael Farkouh, Valentin Fuster, John E Postley, Mark Woodward, Zahi A Fayad

Published in: Journal of Cardiovascular Magnetic Resonance | Issue 1/2009

Login to get access

Abstract

Aims

Patients with prior major cardiovascular or cerebrovascular events (MACE) are more likely to have future recurrent events independent of traditional cardiovascular disease risk factors. The purpose of this study was to determine if patients with traditional risk factors and prior MACE had increased cardiovascular magnetic resonance (CMR) plaque burden measures compared to patients with risk factors but no prior events.

Methods and Results

Black blood carotid and thoracic aorta images were obtained from 195 patients using a rapid extended coverage turbo spin echo sequence. CMR measures of plaque burden were obtained by tracing lumen and outer vessel wall contours. Patients with prior MACE had significantly higher MR plaque burden (wall thickness, wall area and normalized wall index) in carotids and thoracic aorta compared to those without prior MACE (Wall thickness carotids: 1.03 ± 0.03 vs. 0.93± 0.03, p = 0.001; SD wall thickness carotids: 0.137 ± 0.0008 vs. 0.102 ± 0.0004, p < 0.001; wall thickness aorta: 1.63 ± 0.10 vs. 1.50 ± 0.04, p = 0.009; SD wall thickness aorta: 0.186 ± 0.035 vs. 0.139 ± 0.012, p = 0.009 respectively). Plaque burden (wall thickness) and plaque eccentricity (standard deviation of wall thickness) of carotid arteries were associated with prior MACE after adjustment for age, sex, and traditional risk factors. Area under ROC curve (AUC) for discriminating prior MACE improved by adding plaque eccentricity to models incorporating age, sex, and traditional CVD risk factors as model inputs (AUC = 0.79, p = 0.05).

Conclusion

A greater plaque burden and plaque eccentricity is prevalent among patients with prior MACE.
Appendix
Available only for authorised users
Literature
1.
go back to reference Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, Badimon JJ, Stefanadis C, Moreno P, Pasterkamp G, et al: From Vulnerable Plaque to Vulnerable Patient: A Call for New Definitions and Risk Assessment Strategies: Part II. Circulation. 2003, 108: 1772-1778. 10.1161/01.CIR.0000087481.55887.C9.CrossRefPubMed Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, Badimon JJ, Stefanadis C, Moreno P, Pasterkamp G, et al: From Vulnerable Plaque to Vulnerable Patient: A Call for New Definitions and Risk Assessment Strategies: Part II. Circulation. 2003, 108: 1772-1778. 10.1161/01.CIR.0000087481.55887.C9.CrossRefPubMed
2.
go back to reference Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, Badimon JJ, Stefanadis C, Moreno P, Pasterkamp G, et al: From Vulnerable Plaque to Vulnerable Patient: A Call for New Definitions and Risk Assessment Strategies: Part I. Circulation. 2003, 108: 1664-1672. 10.1161/01.CIR.0000087480.94275.97.CrossRefPubMed Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, Badimon JJ, Stefanadis C, Moreno P, Pasterkamp G, et al: From Vulnerable Plaque to Vulnerable Patient: A Call for New Definitions and Risk Assessment Strategies: Part I. Circulation. 2003, 108: 1664-1672. 10.1161/01.CIR.0000087480.94275.97.CrossRefPubMed
3.
go back to reference Gonzalez ER, Kannewurf BS: Atherosclerosis: a unifying disorder with diverse manifestations. Am J Health Syst Pharm. 1998, 55: S4-7.PubMed Gonzalez ER, Kannewurf BS: Atherosclerosis: a unifying disorder with diverse manifestations. Am J Health Syst Pharm. 1998, 55: S4-7.PubMed
4.
go back to reference Paulmier B, Duet M, Khayat R, Pierquet-Ghazzar N, Laissy JP, Maunoury C, Hugonnet F, Sauvaget E, Trinquart L, Faraggi M: Arterial wall uptake of fluorodeoxyglucose on PET imaging in stable cancer disease patients indicates higher risk for cardiovascular events. J Nucl Cardiol. 2008, 15: 209-217. 10.1016/j.nuclcard.2007.10.009.CrossRefPubMed Paulmier B, Duet M, Khayat R, Pierquet-Ghazzar N, Laissy JP, Maunoury C, Hugonnet F, Sauvaget E, Trinquart L, Faraggi M: Arterial wall uptake of fluorodeoxyglucose on PET imaging in stable cancer disease patients indicates higher risk for cardiovascular events. J Nucl Cardiol. 2008, 15: 209-217. 10.1016/j.nuclcard.2007.10.009.CrossRefPubMed
5.
go back to reference Bamberg F, Dannemann N, Shapiro MD, Seneviratne SK, Ferencik M, Butler J, Koenig W, Nasir K, Cury RC, Tawakol A, et al: Association between cardiovascular risk profiles and the presence and extent of different types of coronary atherosclerotic plaque as detected by multidetector computed tomography. Arterioscler Thromb Vasc Biol. 2008, 28: 568-574. 10.1161/ATVBAHA.107.155010.CrossRefPubMed Bamberg F, Dannemann N, Shapiro MD, Seneviratne SK, Ferencik M, Butler J, Koenig W, Nasir K, Cury RC, Tawakol A, et al: Association between cardiovascular risk profiles and the presence and extent of different types of coronary atherosclerotic plaque as detected by multidetector computed tomography. Arterioscler Thromb Vasc Biol. 2008, 28: 568-574. 10.1161/ATVBAHA.107.155010.CrossRefPubMed
6.
go back to reference Feinstein SB, Voci P, Pizzuto F: Noninvasive surrogate markers of atherosclerosis. Am J Cardiol. 2002, 89: 31C-43C. 10.1016/S0002-9149(02)02226-9. discussion 43C–44CCrossRefPubMed Feinstein SB, Voci P, Pizzuto F: Noninvasive surrogate markers of atherosclerosis. Am J Cardiol. 2002, 89: 31C-43C. 10.1016/S0002-9149(02)02226-9. discussion 43C–44CCrossRefPubMed
7.
go back to reference Gullu H, Erdogan D, Caliskan M, Tok D, Yildirim E, Ulus T, Turan Sezgin A, Muderrisoglu H: Interrelationship between noninvasive predictors of atherosclerosis: transthoracic coronary flow reserve, flow-mediated dilation, carotid intima-media thickness, aortic stiffness, aortic distensibility, elastic modulus, and brachial artery diameter. Echocardiography. 2006, 23: 835-842. 10.1111/j.1540-8175.2006.00342.x.CrossRefPubMed Gullu H, Erdogan D, Caliskan M, Tok D, Yildirim E, Ulus T, Turan Sezgin A, Muderrisoglu H: Interrelationship between noninvasive predictors of atherosclerosis: transthoracic coronary flow reserve, flow-mediated dilation, carotid intima-media thickness, aortic stiffness, aortic distensibility, elastic modulus, and brachial artery diameter. Echocardiography. 2006, 23: 835-842. 10.1111/j.1540-8175.2006.00342.x.CrossRefPubMed
8.
go back to reference Crouse JR, Byington RP, Bond MG, Espeland MA, Sprinkle JW, McGovern M, Furberg CD: Pravastatin, lipids, and atherosclerosis in the carotid arteries: design features of a clinical trial with carotid atherosclerosis outcome. Control Clin Trials. 1992, 13: 495-506. 10.1016/0197-2456(92)90206-F.CrossRefPubMed Crouse JR, Byington RP, Bond MG, Espeland MA, Sprinkle JW, McGovern M, Furberg CD: Pravastatin, lipids, and atherosclerosis in the carotid arteries: design features of a clinical trial with carotid atherosclerosis outcome. Control Clin Trials. 1992, 13: 495-506. 10.1016/0197-2456(92)90206-F.CrossRefPubMed
9.
go back to reference Gorter PM, Visseren FL, Algra A, Graaf van der Y: The impact of site and extent of clinically evident cardiovascular disease and atherosclerotic burden on new cardiovascular events in patients with Type 2 diabetes. The SMART study. Diabet Med. 2007, 24: 1352-1360. 10.1111/j.1464-5491.2007.02323.x.CrossRefPubMed Gorter PM, Visseren FL, Algra A, Graaf van der Y: The impact of site and extent of clinically evident cardiovascular disease and atherosclerotic burden on new cardiovascular events in patients with Type 2 diabetes. The SMART study. Diabet Med. 2007, 24: 1352-1360. 10.1111/j.1464-5491.2007.02323.x.CrossRefPubMed
10.
go back to reference Gorter PM, Olijhoek JK, Graaf van der Y, Algra A, Rabelink TJ, Visseren FL: Prevalence of the metabolic syndrome in patients with coronary heart disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm. Atherosclerosis. 2004, 173: 363-369. 10.1016/j.atherosclerosis.2003.12.033.CrossRefPubMed Gorter PM, Olijhoek JK, Graaf van der Y, Algra A, Rabelink TJ, Visseren FL: Prevalence of the metabolic syndrome in patients with coronary heart disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm. Atherosclerosis. 2004, 173: 363-369. 10.1016/j.atherosclerosis.2003.12.033.CrossRefPubMed
11.
go back to reference Hatsukami TS, Ross R, Polissar NL, Yuan C: Visualization of fibrous cap thickness and rupture in human atherosclerotic carotid plaque in vivo with high-resolution magnetic resonance imaging. Circulation. 2000, 102: 959-964.CrossRefPubMed Hatsukami TS, Ross R, Polissar NL, Yuan C: Visualization of fibrous cap thickness and rupture in human atherosclerotic carotid plaque in vivo with high-resolution magnetic resonance imaging. Circulation. 2000, 102: 959-964.CrossRefPubMed
12.
go back to reference Trivedi RA, JM UK-I, Graves MJ, Horsley J, Goddard M, Kirkpatrick PJ, Gillard JH: MRI-derived measurements of fibrous-cap and lipid-core thickness: the potential for identifying vulnerable carotid plaques in vivo. Neuroradiology. 2004, 46: 738-743. 10.1007/s00234-004-1247-6.CrossRefPubMed Trivedi RA, JM UK-I, Graves MJ, Horsley J, Goddard M, Kirkpatrick PJ, Gillard JH: MRI-derived measurements of fibrous-cap and lipid-core thickness: the potential for identifying vulnerable carotid plaques in vivo. Neuroradiology. 2004, 46: 738-743. 10.1007/s00234-004-1247-6.CrossRefPubMed
13.
go back to reference Yuan C, Mitsumori LM, Ferguson MS, Polissar NL, Echelard D, Ortiz G, Small R, Davies JW, Kerwin WS, Hatsukami TS: In vivo accuracy of multispectral magnetic resonance imaging for identifying lipid-rich necrotic cores and intraplaque hemorrhage in advanced human carotid plaques. Circulation. 2001, 104: 2051-2056. 10.1161/hc4201.097839.CrossRefPubMed Yuan C, Mitsumori LM, Ferguson MS, Polissar NL, Echelard D, Ortiz G, Small R, Davies JW, Kerwin WS, Hatsukami TS: In vivo accuracy of multispectral magnetic resonance imaging for identifying lipid-rich necrotic cores and intraplaque hemorrhage in advanced human carotid plaques. Circulation. 2001, 104: 2051-2056. 10.1161/hc4201.097839.CrossRefPubMed
14.
go back to reference Mohler ER, Sarov-Blat L, Shi Y, Hamamdzic D, Zalewski A, Macphee C, Llano R, Pelchovitz D, Mainigi SK, Osman H, et al: Site-Specific Atherogenic Gene Expression Correlates With Subsequent Variable Lesion Development in Coronary and Peripheral Vasculature. Arterioscler Thromb Vasc Biol. 2008 Mohler ER, Sarov-Blat L, Shi Y, Hamamdzic D, Zalewski A, Macphee C, Llano R, Pelchovitz D, Mainigi SK, Osman H, et al: Site-Specific Atherogenic Gene Expression Correlates With Subsequent Variable Lesion Development in Coronary and Peripheral Vasculature. Arterioscler Thromb Vasc Biol. 2008
15.
go back to reference Kardys I, Vliegenthart R, Oudkerk M, Hofman A, Witteman JC: The female advantage in cardiovascular disease: do vascular beds contribute equally?. Am J Epidemiol. 2007, 166: 403-412. 10.1093/aje/kwm115.CrossRefPubMed Kardys I, Vliegenthart R, Oudkerk M, Hofman A, Witteman JC: The female advantage in cardiovascular disease: do vascular beds contribute equally?. Am J Epidemiol. 2007, 166: 403-412. 10.1093/aje/kwm115.CrossRefPubMed
16.
go back to reference Sutton-Tyrrell K, Kuller LH, Matthews KA, Holubkov R, Patel A, Edmundowicz D, Newman A: Subclinical atherosclerosis in multiple vascular beds: an index of atherosclerotic burden evaluated in postmenopausal women. Atherosclerosis. 2002, 160: 407-416. 10.1016/S0021-9150(01)00591-3.CrossRefPubMed Sutton-Tyrrell K, Kuller LH, Matthews KA, Holubkov R, Patel A, Edmundowicz D, Newman A: Subclinical atherosclerosis in multiple vascular beds: an index of atherosclerotic burden evaluated in postmenopausal women. Atherosclerosis. 2002, 160: 407-416. 10.1016/S0021-9150(01)00591-3.CrossRefPubMed
17.
go back to reference Kastelein JJ, Akdim F, Stroes ES, Zwinderman AH, Bots ML, Stalenhoef AF, Visseren FL, Sijbrands EJ, Trip MD, Stein EA, et al: Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med. 2008, 358: 1431-1443. 10.1056/NEJMoa0800742.CrossRefPubMed Kastelein JJ, Akdim F, Stroes ES, Zwinderman AH, Bots ML, Stalenhoef AF, Visseren FL, Sijbrands EJ, Trip MD, Stein EA, et al: Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med. 2008, 358: 1431-1443. 10.1056/NEJMoa0800742.CrossRefPubMed
18.
go back to reference Brown BG, Taylor AJ: Does ENHANCE diminish confidence in lowering LDL or in ezetimibe?. N Engl J Med. 2008, 358: 1504-1507. 10.1056/NEJMe0801608.CrossRefPubMed Brown BG, Taylor AJ: Does ENHANCE diminish confidence in lowering LDL or in ezetimibe?. N Engl J Med. 2008, 358: 1504-1507. 10.1056/NEJMe0801608.CrossRefPubMed
19.
go back to reference Drazen JM, Jarcho JA, Morrissey S, Curfman GD: Cholesterol lowering and ezetimibe. N Engl J Med. 2008, 358: 1507-1508. 10.1056/NEJMe0801842.CrossRefPubMed Drazen JM, Jarcho JA, Morrissey S, Curfman GD: Cholesterol lowering and ezetimibe. N Engl J Med. 2008, 358: 1507-1508. 10.1056/NEJMe0801842.CrossRefPubMed
20.
go back to reference Mani V, Itskovich VV, Aguiar SH, Mizsei G, Aguinaldo JG, Samber DD, Macaluso FM, Fayad ZA: Comparison of gated and non-gated fast multislice black-blood carotid imaging using rapid extended coverage and inflow/outflow saturation techniques. J Magn Reson Imaging. 2005, 22: 628-633. 10.1002/jmri.20428.CrossRefPubMed Mani V, Itskovich VV, Aguiar SH, Mizsei G, Aguinaldo JG, Samber DD, Macaluso FM, Fayad ZA: Comparison of gated and non-gated fast multislice black-blood carotid imaging using rapid extended coverage and inflow/outflow saturation techniques. J Magn Reson Imaging. 2005, 22: 628-633. 10.1002/jmri.20428.CrossRefPubMed
21.
go back to reference Mani V, Itskovich VV, Szimtenings M, Aguinaldo JG, Samber DD, Mizsei G, Fayad ZA: Rapid extended coverage simultaneous multisection black-blood vessel wall MR imaging. Radiology. 2004, 232: 281-288. 10.1148/radiol.2321031022.CrossRefPubMed Mani V, Itskovich VV, Szimtenings M, Aguinaldo JG, Samber DD, Mizsei G, Fayad ZA: Rapid extended coverage simultaneous multisection black-blood vessel wall MR imaging. Radiology. 2004, 232: 281-288. 10.1148/radiol.2321031022.CrossRefPubMed
22.
go back to reference Yuan C, Kerwin WS, Yarnykh VL, Cai J, Saam T, Chu B, Takaya N, Ferguson MS, Underhill H, Xu D, et al: MRI of atherosclerosis in clinical trials. NMR Biomed. 2006, 19: 636-654. 10.1002/nbm.1065.CrossRefPubMed Yuan C, Kerwin WS, Yarnykh VL, Cai J, Saam T, Chu B, Takaya N, Ferguson MS, Underhill H, Xu D, et al: MRI of atherosclerosis in clinical trials. NMR Biomed. 2006, 19: 636-654. 10.1002/nbm.1065.CrossRefPubMed
23.
go back to reference Wasserman BA, Sharrett AR, Lai S, Gomes AS, Cushman M, Folsom AR, Bild DE, Kronmal RA, Sinha S, Bluemke DA: Risk factor associations with the presence of a lipid core in carotid plaque of asymptomatic individuals using high-resolution MRI: the multi-ethnic study of atherosclerosis (MESA). Stroke. 2008, 39: 329-335. 10.1161/STROKEAHA.107.498634.CrossRefPubMed Wasserman BA, Sharrett AR, Lai S, Gomes AS, Cushman M, Folsom AR, Bild DE, Kronmal RA, Sinha S, Bluemke DA: Risk factor associations with the presence of a lipid core in carotid plaque of asymptomatic individuals using high-resolution MRI: the multi-ethnic study of atherosclerosis (MESA). Stroke. 2008, 39: 329-335. 10.1161/STROKEAHA.107.498634.CrossRefPubMed
24.
go back to reference Saam T, Hatsukami TS, Yarnykh VL, Hayes CE, Underhill H, Chu B, Takaya N, Cai J, Kerwin WS, Xu D, et al: Reader and platform reproducibility for quantitative assessment of carotid atherosclerotic plaque using 1.5T Siemens, Philips, and General Electric scanners. J Magn Reson Imaging. 2007, 26: 344-352. 10.1002/jmri.21004.CrossRefPubMed Saam T, Hatsukami TS, Yarnykh VL, Hayes CE, Underhill H, Chu B, Takaya N, Cai J, Kerwin WS, Xu D, et al: Reader and platform reproducibility for quantitative assessment of carotid atherosclerotic plaque using 1.5T Siemens, Philips, and General Electric scanners. J Magn Reson Imaging. 2007, 26: 344-352. 10.1002/jmri.21004.CrossRefPubMed
25.
go back to reference Takaya N, Cai J, Ferguson MS, Yarnykh VL, Chu B, Saam T, Polissar NL, Sherwood J, Cury RC, Anders RJ, et al: Intra- and interreader reproducibility of magnetic resonance imaging for quantifying the lipid-rich necrotic core is improved with gadolinium contrast enhancement. J Magn Reson Imaging. 2006, 24: 203-210. 10.1002/jmri.20599.CrossRefPubMed Takaya N, Cai J, Ferguson MS, Yarnykh VL, Chu B, Saam T, Polissar NL, Sherwood J, Cury RC, Anders RJ, et al: Intra- and interreader reproducibility of magnetic resonance imaging for quantifying the lipid-rich necrotic core is improved with gadolinium contrast enhancement. J Magn Reson Imaging. 2006, 24: 203-210. 10.1002/jmri.20599.CrossRefPubMed
26.
go back to reference Saam T, Kerwin WS, Chu B, Cai J, Kampschulte A, Hatsukami TS, Zhao XQ, Polissar NL, Neradilek B, Yarnykh VL, et al: Sample size calculation for clinical trials using magnetic resonance imaging for the quantitative assessment of carotid atherosclerosis. J Cardiovasc Magn Reson. 2005, 7: 799-808. 10.1080/10976640500287703.CrossRefPubMed Saam T, Kerwin WS, Chu B, Cai J, Kampschulte A, Hatsukami TS, Zhao XQ, Polissar NL, Neradilek B, Yarnykh VL, et al: Sample size calculation for clinical trials using magnetic resonance imaging for the quantitative assessment of carotid atherosclerosis. J Cardiovasc Magn Reson. 2005, 7: 799-808. 10.1080/10976640500287703.CrossRefPubMed
27.
go back to reference Touze E, Toussaint JF, Coste J, Schmitt E, Bonneville F, Vandermarcq P, Gauvrit JY, Douvrin F, Meder JF, Mas JL, Oppenheim C: Reproducibility of high-resolution MRI for the identification and the quantification of carotid atherosclerotic plaque components: consequences for prognosis studies and therapeutic trials. Stroke. 2007, 38: 1812-1819. 10.1161/STROKEAHA.106.479139.CrossRefPubMed Touze E, Toussaint JF, Coste J, Schmitt E, Bonneville F, Vandermarcq P, Gauvrit JY, Douvrin F, Meder JF, Mas JL, Oppenheim C: Reproducibility of high-resolution MRI for the identification and the quantification of carotid atherosclerotic plaque components: consequences for prognosis studies and therapeutic trials. Stroke. 2007, 38: 1812-1819. 10.1161/STROKEAHA.106.479139.CrossRefPubMed
28.
go back to reference Geest van der RJ, Reiber JH: Quantification in cardiac MRI. J Magn Reson Imaging. 1999, 10: 602-608. 10.1002/(SICI)1522-2586(199911)10:5<602::AID-JMRI3>3.0.CO;2-C.CrossRefPubMed Geest van der RJ, Reiber JH: Quantification in cardiac MRI. J Magn Reson Imaging. 1999, 10: 602-608. 10.1002/(SICI)1522-2586(199911)10:5<602::AID-JMRI3>3.0.CO;2-C.CrossRefPubMed
29.
go back to reference Kerwin W, Xu D, Liu F, Saam T, Underhill H, Takaya N, Chu B, Hatsukami T, Yuan C: Magnetic resonance imaging of carotid atherosclerosis: plaque analysis. Top Magn Reson Imaging. 2007, 18: 371-378. 10.1097/rmr.0b013e3181598d9d.CrossRefPubMed Kerwin W, Xu D, Liu F, Saam T, Underhill H, Takaya N, Chu B, Hatsukami T, Yuan C: Magnetic resonance imaging of carotid atherosclerosis: plaque analysis. Top Magn Reson Imaging. 2007, 18: 371-378. 10.1097/rmr.0b013e3181598d9d.CrossRefPubMed
30.
go back to reference Saam T, Yuan C, Chu B, Takaya N, Underhill H, Cai J, Tran N, Polissar NL, Neradilek B, Jarvik GP, et al: Predictors of carotid atherosclerotic plaque progression as measured by noninvasive magnetic resonance imaging. Atherosclerosis. 2007, 194: e34-42. 10.1016/j.atherosclerosis.2006.08.016.PubMedCentralCrossRefPubMed Saam T, Yuan C, Chu B, Takaya N, Underhill H, Cai J, Tran N, Polissar NL, Neradilek B, Jarvik GP, et al: Predictors of carotid atherosclerotic plaque progression as measured by noninvasive magnetic resonance imaging. Atherosclerosis. 2007, 194: e34-42. 10.1016/j.atherosclerosis.2006.08.016.PubMedCentralCrossRefPubMed
31.
go back to reference DeLong ER, DeLong DM, Clarke-Pearson DL: Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988, 44: 837-845. 10.2307/2531595.CrossRefPubMed DeLong ER, DeLong DM, Clarke-Pearson DL: Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988, 44: 837-845. 10.2307/2531595.CrossRefPubMed
32.
go back to reference Riccioni G, De Santis A, Cerasa V, Menna V, Di Ilio C, Schiavone C, Ballone E, D'Orazio N: Atherosclerotic plaque formation and risk factors. Int J Immunopathol Pharmacol. 2003, 16: 25-31.PubMed Riccioni G, De Santis A, Cerasa V, Menna V, Di Ilio C, Schiavone C, Ballone E, D'Orazio N: Atherosclerotic plaque formation and risk factors. Int J Immunopathol Pharmacol. 2003, 16: 25-31.PubMed
33.
go back to reference Romero JR: Prevention of ischemic stroke: overview of traditional risk factors. Curr Drug Targets. 2007, 8: 794-801. 10.2174/138945007781077373.CrossRefPubMed Romero JR: Prevention of ischemic stroke: overview of traditional risk factors. Curr Drug Targets. 2007, 8: 794-801. 10.2174/138945007781077373.CrossRefPubMed
34.
go back to reference Morka J, Krzeminska-Pakula M, Drozdz J, Morka A: Factors affecting the progression of atherosclerosis in the coronary arteries. Kardiol Pol. 2007, 65: 1307-1311.PubMed Morka J, Krzeminska-Pakula M, Drozdz J, Morka A: Factors affecting the progression of atherosclerosis in the coronary arteries. Kardiol Pol. 2007, 65: 1307-1311.PubMed
35.
go back to reference Sobel BE: Optimizing cardiovascular outcomes in diabetes mellitus. Am J Med. 2007, 120: S3-11. 10.1016/j.amjmed.2007.07.002.CrossRefPubMed Sobel BE: Optimizing cardiovascular outcomes in diabetes mellitus. Am J Med. 2007, 120: S3-11. 10.1016/j.amjmed.2007.07.002.CrossRefPubMed
36.
go back to reference Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ: Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med. 1987, 316: 1371-1375.CrossRefPubMed Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ: Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med. 1987, 316: 1371-1375.CrossRefPubMed
37.
go back to reference Ashida K, Momiyama Y, Fayad ZA, Tanaka N, Kato R, Taniguchi H, Ohmori R, Kihara T, Kameyama A, Nagata M, et al: Magnetic resonance evaluation of the associations of thoracic and abdominal aortic plaques with the presence and extent of coronary artery stenosis. J Cardiovasc Magn Reson. 2007, 9: 855-861. 10.1080/10976640701693584.CrossRefPubMed Ashida K, Momiyama Y, Fayad ZA, Tanaka N, Kato R, Taniguchi H, Ohmori R, Kihara T, Kameyama A, Nagata M, et al: Magnetic resonance evaluation of the associations of thoracic and abdominal aortic plaques with the presence and extent of coronary artery stenosis. J Cardiovasc Magn Reson. 2007, 9: 855-861. 10.1080/10976640701693584.CrossRefPubMed
38.
go back to reference Momiyama Y, Fayad ZA: Aortic plaque imaging and monitoring atherosclerotic plaque interventions. Top Magn Reson Imaging. 2007, 18: 349-355. 10.1097/rmr.0b013e31815a0e5d.CrossRefPubMed Momiyama Y, Fayad ZA: Aortic plaque imaging and monitoring atherosclerotic plaque interventions. Top Magn Reson Imaging. 2007, 18: 349-355. 10.1097/rmr.0b013e31815a0e5d.CrossRefPubMed
39.
go back to reference Yonemura A, Momiyama Y, Fayad ZA, Ayaori M, Ohmori R, Higashi K, Kihara T, Sawada S, Iwamoto N, Ogura M, et al: Effect of lipid-lowering therapy with atorvastatin on atherosclerotic aortic plaques detected by noninvasive magnetic resonance imaging. J Am Coll Cardiol. 2005, 45: 733-742. 10.1016/j.jacc.2004.11.039.CrossRefPubMed Yonemura A, Momiyama Y, Fayad ZA, Ayaori M, Ohmori R, Higashi K, Kihara T, Sawada S, Iwamoto N, Ogura M, et al: Effect of lipid-lowering therapy with atorvastatin on atherosclerotic aortic plaques detected by noninvasive magnetic resonance imaging. J Am Coll Cardiol. 2005, 45: 733-742. 10.1016/j.jacc.2004.11.039.CrossRefPubMed
40.
go back to reference El Aidi H, Mani V, Weinshelbaum KB, Aguiar SH, Taniguchi H, Postley JE, Samber DD, Cohen EI, Stern J, Geest van der RJ, et al: Cross-sectional, prospective study of MRI reproducibility in the assessment of plaque burden of the carotid arteries and aorta. Nat Clin Pract Cardiovasc Med. 2009, 6: 219-228. 10.1038/ncpcardio1444.CrossRefPubMed El Aidi H, Mani V, Weinshelbaum KB, Aguiar SH, Taniguchi H, Postley JE, Samber DD, Cohen EI, Stern J, Geest van der RJ, et al: Cross-sectional, prospective study of MRI reproducibility in the assessment of plaque burden of the carotid arteries and aorta. Nat Clin Pract Cardiovasc Med. 2009, 6: 219-228. 10.1038/ncpcardio1444.CrossRefPubMed
41.
go back to reference Woodward M: Epidemiology: Study Design and Data Analysis. 2005, Boca Raton: Chapman and Hall/CRC Press, Second Woodward M: Epidemiology: Study Design and Data Analysis. 2005, Boca Raton: Chapman and Hall/CRC Press, Second
42.
go back to reference Yuan C, Beach KW, Smith LH, Hatsukami TS: Measurement of atherosclerotic carotid plaque size in vivo using high resolution magnetic resonance imaging. Circulation. 1998, 98: 2666-2671.CrossRefPubMed Yuan C, Beach KW, Smith LH, Hatsukami TS: Measurement of atherosclerotic carotid plaque size in vivo using high resolution magnetic resonance imaging. Circulation. 1998, 98: 2666-2671.CrossRefPubMed
Metadata
Title
Cardiovascular magnetic resonance parameters of atherosclerotic plaque burden improve discrimination of prior major adverse cardiovascular events
Authors
Venkatesh Mani
Paul Muntner
Samuel S Gidding
Silvia H Aguiar
Hamza El Aidi
Karen B Weinshelbaum
Hiroaki Taniguchi
Rob van der Geest
Johan HC Reiber
Sameer Bansilal
Michael Farkouh
Valentin Fuster
John E Postley
Mark Woodward
Zahi A Fayad
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Journal of Cardiovascular Magnetic Resonance / Issue 1/2009
Electronic ISSN: 1532-429X
DOI
https://doi.org/10.1186/1532-429X-11-10

Other articles of this Issue 1/2009

Journal of Cardiovascular Magnetic Resonance 1/2009 Go to the issue